Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Coagulation Testing Market , by Product Type (Instruments, Consumables), by Application (Prothrombin Time, Activated Partial Thromboplastin Time, Thrombin Time, Activated Clotting Time), by End-Use (Hospitals, Clinical Laboratories, Point-of-Care Testing, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026

  • RES4072075
  • 105 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
The global coagulation testing market will generate a revenue of $3,566.0 million by 2026, rising from $2,241.4 million in 2018 at a CAGR of 5.9%.

Blood Coagulation (clotting) is a change in the physical properties of blood due to the conversion of a fibrinogen, soluble plasma protein, into a fibrin, solid gel. Coagulation tests are primarily carried out by coagulometer which analyzes the ability of the blood to clot and the time span it takes to clot.

Increasing number of special coagulation laboratories is one of the major factors for the growth of coagulation testing market. Highly advanced technologies like microfluidics, fluorescent microscopy, photoacoustic detection and others are utilized to develop economic point of care devices. Point of care (POC) devices mainly measure mechanical, electrochemical and other parameters of blood clots. These innovations are expected to augment the coagulation testing market growth. Contrary to this, high costs of devices as well as lack of experienced professionals may obstruct the growth of global coagulation market. The smartphone-based coagulation test is projected to fuel the coagulation testing market growth. In this self-testing technology, all measured data of coagulation tests is sent on a smartphone by using Bluetooth for results computation. Two important coagulation indexes like activated partial thromboplastin time and prothrombin time could be measured on this advanced platform that which is reliable and effective. These technology advances are projected to create lucrative opportunities for the growth of the coagulation testing market.

Consumable type has the largest share in the global market, and it has generated a revenue of $1,187.9 million in 2018 and is projected to cross $1,847.2 million by 2026.

Instruments type is the fastest progressing market globally and it shall surpass $1,718.8 Million by 2026.

Prothrombin time application shall register a revenue of $2,475.7 million during the projected period. The increasing number of CVD patients (cardiovascular diseases), blood disorders coupled with growing demand for point of care testing is anticipated to drive the global market growth, over the projected period. Thrombin time application shall generate a revenue of $392.3 million over the forecasted period.

Point-of-Care segment is the fastest growing segment in the market, and it has generated a revenue of $291.4 million in 2018 and is anticipated to surpass $495.7 million by 2026. The rising economic pressures on hospitals and clinics along with increasing competitiveness among suppliers and therapist, is projected to foster the growth of the market. Hospitals segment has the highest share in the global market, and it will cross $829.3 million in 2018 and is anticipated to surpass $1,290.9 million, during the projected period.

Europe Coagulation Testing market is projected to increase at a healthy CAGR of 6.2% by registering a revenue of $1,094.8 million by 2026. Asia-Pacific Coagulation Testing market will surpass $848.7 million by 2026. Extensively rising demand for foreign investments and heavy investment for R&D of coagulation test devices in Asian countries such as China and India are projected to add to the growth of coagulation testing market in this region.

Some of the leading Coagulation Testing market players include Helena Laboratories Corporation., Thermo Fisher Scientific Inc., Medtronic, Micropoint Biosciences, NIHON KOHDEN CORPORATION., F. Hoffmann-La Roche Ltd, Sysmex Corporation, Abbott., BD., and Danaher.

1. Research Methodology

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.4.1. Assumptions

1.4.2. Forecast parameters

1.5. Data sources

1.5.1. Primary

1.5.2. Secondary

2. Executive Summary

2.1. 360° summary

2.2. Product Type Trends

2.3. Application Trends

2.4. End Use Trends

3. Market Overview

3.1. Market segmentation & definitions

3.2. Key takeaways

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of consumers

3.3.2. Bargaining power of suppliers

3.3.3. Threat of new entrants

3.3.4. Threat of substitutes

3.3.5. Competitive rivalry in the market

3.4. Market dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.5. Technology landscape

3.6. Regulatory landscape

3.7. Patent landscape

3.8. Strategic overview

4. Coagulation Test Market, by Product Type

4.1. Printers

4.1.1. Market size and forecast, by region, 2018-2026

4.1.2. Comparative market share analysis, 2018 & 2026

4.2. Materials

4.2.1. Market size and forecast, by region, 2018-2026

4.2.2. Comparative market share analysis, 2018 & 2026

5. Coagulation Test Market, by Application

5.1. Prothrombin Time

5.1.1. Market size and forecast, by region, 2018-2026

5.1.2. Comparative market share analysis, 2018 & 2026

5.2. Activated Partial Thromboplastin Time

5.2.1. Market size and forecast, by region, 2018-2026

5.2.2. Comparative market share analysis, 2018 & 2026

5.3. Thrombin Time

5.3.1. Market size and forecast, by region, 2018-2026

5.3.2. Comparative market share analysis, 2018 & 2026

5.4. Activated Clotting Time

5.4.1. Market size and forecast, by region, 2018-2026

5.4.2. Comparative market share analysis, 2018 & 2026

6. Coagulation Test Market, by End Use

6.1. Hospitals

6.1.1. Market size and forecast, by region, 2018-2026

6.1.2. Comparative market share analysis, 2018 & 2026

6.2. Clinical Laboratories

6.2.1. Market size and forecast, by region, 2018-2026

6.2.2. Comparative market share analysis, 2018 & 2026

6.3. Point-of-Care Testing

6.3.1. Market size and forecast, by region, 2018-2026

6.3.2. Comparative market share analysis, 2018 & 2026

6.4. Others

6.4.1. Market size and forecast, by region, 2018-2026

6.4.2. Comparative market share analysis, 2018 & 2026

7. Coagulation Test Market, by Region

7.1. North America

7.1.1. Market size and forecast, by product type, 2018-2026

7.1.2. Market size and forecast, by application, 2018-2026

7.1.3. Market size and forecast, by end use, 2018-2026

7.1.4. Market size and forecast, by country, 2018-2026

7.1.5. Comparative market share analysis, 2018 & 2026

7.1.6. U.S.

7.1.6.1. Market size and forecast, by product type, 2018-2026

7.1.6.2. Market size and forecast, by application, 2018-2026

7.1.6.3. Market size and forecast, by end use, 2018-2026

7.1.6.4. Comparative market share analysis, 2018 & 2026

7.1.7. Canada

7.1.7.1. Market size and forecast, by product type, 2018-2026

7.1.7.2. Market size and forecast, by application, 2018-2026

7.1.7.3. Market size and forecast, by end use, 2018-2026

7.1.7.4. Comparative market share analysis, 2018 & 2026

7.2. Europe

7.2.1. Market size and forecast, by product type, 2018-2026

7.2.2. Market size and forecast, by application, 2018-2026

7.2.3. Market size and forecast, by end use, 2018-2026

7.2.4. Market size and forecast, by country, 2018-2026

7.2.5. Comparative market share analysis, 2018 & 2026

7.2.6. Germany

7.2.6.1. Market size and forecast, by product type, 2018-2026

7.2.6.2. Market size and forecast, by application, 2018-2026

7.2.6.3. Market size and forecast, by end use, 2018-2026

7.2.6.4. Comparative market share analysis, 2018 & 2026

7.2.7. UK

7.2.7.1. Market size and forecast, by product type, 2018-2026

7.2.7.2. Market size and forecast, by application, 2018-2026

7.2.7.3. Market size and forecast, by end use, 2018-2026

7.2.7.4. Comparative market share analysis, 2018 & 2026

7.2.8. France

7.2.8.1. Market size and forecast, by product type, 2018-2026

7.2.8.2. Market size and forecast, by application, 2018-2026

7.2.8.3. Market size and forecast, by end use, 2018-2026

7.2.8.4. Comparative market share analysis, 2018 & 2026

7.2.9. Spain

7.2.9.1. Market size and forecast, by product type, 2018-2026

7.2.9.2. Market size and forecast, by application, 2018-2026

7.2.9.3. Market size and forecast, by end use, 2018-2026

7.2.9.4. Comparative market share analysis, 2018 & 2026

7.2.10. Italy

7.2.10.1. Market size and forecast, by product type, 2018-2026

7.2.10.2. Market size and forecast, by application, 2018-2026

7.2.10.3. Market size and forecast, by end use, 2018-2026

7.2.10.4. Comparative market share analysis, 2018 & 2026

7.2.11. Rest of Europe

7.2.11.1. Market size and forecast, by product type, 2018-2026

7.2.11.2. Market size and forecast, by application, 2018-2026

7.2.11.3. Market size and forecast, by end use, 2018-2026

7.2.11.4. Comparative market share analysis, 2018 & 2026

7.3. Asia Pacific

7.3.1. Market size and forecast, by product type, 2018-2026

7.3.2. Market size and forecast, by application, 2018-2026

7.3.3. Market size and forecast, by end use, 2018-2026

7.3.4. Market size and forecast, by country, 2018-2026

7.3.5. Comparative market share analysis, 2018 & 2026

7.3.6. China

7.3.6.1. Market size and forecast, by product type, 2018-2026

7.3.6.2. Market size and forecast, by application, 2018-2026

7.3.6.3. Market size and forecast, by end use, 2018-2026

7.3.6.4. Comparative market share analysis, 2018 & 2026

7.3.7. India

7.3.7.1. Market size and forecast, by product type, 2018-2026

7.3.7.2. Market size and forecast, by application, 2018-2026

7.3.7.3. Market size and forecast, by end use, 2018-2026

7.3.7.4. Comparative market share analysis, 2018 & 2026

7.3.8. Australia

7.3.8.1. Market size and forecast, by product type, 2018-2026

7.3.8.2. Market size and forecast, by application, 2018-2026

7.3.8.3. Market size and forecast, by end use, 2018-2026

7.3.8.4. Comparative market share analysis, 2018 & 2026

7.3.9. Rest of Asia Pacific

7.3.9.1. Market size and forecast, by product type, 2018-2026

7.3.9.2. Market size and forecast, by application, 2018-2026

7.3.9.3. Market size and forecast, by end use, 2018-2026

7.3.9.4. Comparative market share analysis, 2018 & 2026

7.4. LAMEA

7.4.1. Market size and forecast, by product type, 2018-2026

7.4.2. Market size and forecast, by application, 2018-2026

7.4.3. Market size and forecast, by end use, 2018-2026

7.4.4. Market size and forecast, by country, 2018-2026

7.4.5. Comparative market share analysis, 2018 & 2026

7.4.6. Latin America

7.4.6.1. Market size and forecast, by product type, 2018-2026

7.4.6.2. Market size and forecast, by application, 2018-2026

7.4.6.3. Market size and forecast, by end use, 2018-2026

7.4.6.4. Comparative market share analysis, 2018 & 2026

7.4.7. Middle East

7.4.7.1. Market size and forecast, by product type, 2018-2026

7.4.7.2. Market size and forecast, by application, 2018-2026

7.4.7.3. Market size and forecast, by end use, 2018-2026

7.4.7.4. Comparative market share analysis, 2018 & 2026

7.4.8. Africa

7.4.8.1. Market size and forecast, by product type, 2018-2026

7.4.8.2. Market size and forecast, by application, 2018-2026

7.4.8.3. Market size and forecast, by end use, 2018-2026

7.4.8.4. Comparative market share analysis, 2018 & 2026

8. Company Profiles

8.1. Thermo Fisher Scientific Inc.

8.1.1. Business overview

8.1.2. Financial performance

8.1.3. Product portfolio

8.1.4. Recent strategic moves & developments

8.1.5. SWOT analysis

8.2. Helena Laboratories Corporation.

8.2.1. Business overview

8.2.2. Financial performance

8.2.3. Product portfolio

8.2.4. Recent strategic moves & developments

8.2.5. SWOT analysis

8.3. Micropoint Biosciences

8.3.1. Business overview

8.3.2. Financial performance

8.3.3. Product portfolio

8.3.4. Recent strategic moves & developments

8.3.5. SWOT analysis

8.4. Medtronic

8.4.1. Business overview

8.4.2. Financial performance

8.4.3. Product portfolio

8.4.4. Recent strategic moves & developments

8.4.5. SWOT analysis

8.5. F. Hoffmann-La Roche Ltd

8.5.1. Business overview

8.5.2. Financial performance

8.5.3. Product portfolio

8.5.4. Recent strategic moves & developments

8.5.5. SWOT analysis

8.6. NIHON KOHDEN CORPORATION.

8.6.1. Business overview

8.6.2. Financial performance

8.6.3. Product portfolio

8.6.4. Recent strategic moves & developments

8.6.5. SWOT analysis

8.7. Abbott.

8.7.1. Business overview

8.7.2. Financial performance

8.7.3. Product portfolio

8.7.4. Recent strategic moves & developments

8.7.5. SWOT analysis

8.8. Sysmex Corporation

8.8.1. Business overview

8.8.2. Financial performance

8.8.3. Product portfolio

8.8.4. Recent strategic moves & developments

8.8.5. SWOT analysis

8.9. BD.

8.9.1. Business overview

8.9.2. Financial performance

8.9.3. Product portfolio

8.9.4. Recent strategic moves & developments

8.9.5. SWOT analysis

8.10. Danaher.

8.10.1. Business overview

8.10.2. Financial performance

8.10.3. Product portfolio

8.10.4. Recent strategic moves & developments

8.10.5. SWOT analysis

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research